The Apprentice Doctor

Multiple Myeloma

Discussion in 'Case Studies' started by Essam Abdelhakim, Mar 6, 2025.

  1. Essam Abdelhakim

    Essam Abdelhakim Well-Known Member

    Joined:
    Jan 27, 2025
    Messages:
    131
    Likes Received:
    4
    Trophy Points:
    205
    Gender:
    Male
    Practicing medicine in:
    United Kingdom

    • A 68-year-old male presents with fatigue, back pain, and recurrent infections for 6 months.
    • On examination:
      • Pale, mild tenderness over the lumbar spine.
    • Lab Findings:
      • CBC: Hb 9.8 g/dL, WBC 4,500/µL, Platelets 210,000/µL.
      • Serum calcium: 12.5 mg/dL (elevated).
      • Renal function: Creatinine 2.1 mg/dL (elevated).
      • Serum protein electrophoresis (SPEP): Monoclonal M-spike (IgG).
      • Urine Bence Jones protein: Positive.
      • Skeletal survey: Multiple lytic lesions in vertebrae.
      • Bone marrow biopsy: >10% plasma cells.
    Key Clinical Features:

    • Elderly patient with bone pain, anemia, renal dysfunction, and hypercalcemia → Suggestive of multiple myeloma.
    • M-spike on SPEP + bone marrow plasma cell infiltration confirms diagnosis.
    • Recurrent infections due to immunoglobulin suppression.
    Differential Diagnosis:

    • MGUS (Monoclonal Gammopathy of Undetermined Significance) – M-spike <3 g/dL, no organ damage.
    • Waldenström Macroglobulinemia – IgM monoclonal spike, hyperviscosity symptoms.
    • Metastatic bone disease – No monoclonal protein, solid tumor history.
    Investigations & Workup:

    • Serum and urine protein electrophoresis → Detect monoclonal protein.
    • Bone marrow biopsy → Confirms >10% plasma cells.
    • Imaging (X-ray/MRI/PET-CT) → Look for lytic lesions.
    • Cytogenetics (FISH analysis) → Prognostic markers (e.g., del(17p), t(4;14)).
    Final Diagnosis & Management Plan:

    • Diagnosis: Multiple Myeloma (IgG subtype).
    • Treatment:
      • Initial therapy: Bortezomib + Lenalidomide + Dexamethasone (VRd).
      • Autologous stem cell transplant (ASCT) for eligible patients.
      • Bisphosphonates (e.g., Zoledronic acid) for bone protection.
      • Supportive care: Infection prophylaxis, renal protection.
    MCQs with Answers & Explanations:

    Q1. What is the most common monoclonal protein in multiple myeloma?
    A) IgA
    B) IgG
    C) IgM
    D) Free light chains

    Correct Answer: B) IgG
    Explanation: IgG is the most common monoclonal protein in multiple myeloma (60–70%), followed by IgA. IgM is characteristic of Waldenström macroglobulinemia.
     

    Add Reply

Share This Page

<